Lactic acidosis and multiorgan failure secondary to antiretroviral treatments in HIV-infected patients

被引:0
|
作者
Mégarbane, B
Brivet, F
Guérin, JM
Baud, FJ
机构
[1] Hop Antoine Beclere, Serv Reanimat Med & Urgences Med, Clamart, France
[2] Hop Lariboisiere, Serv Reanimat Med & Toxicol, F-75010 Paris, France
来源
PRESSE MEDICALE | 1999年 / 28卷 / 40期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A serious complication: Antiretroviral therapy may induce severe lactic acidosis with multiorgan failure in HIV-infected patients. Clinical description: Patients are admitted for onset of dyspnea, abdominal pain, nausea, vomiting or diarrhea, with weight loss and general fatigue over the past few days. Physical findings are usually not contributive except for constant presence of hepatomegaly. Laboratory examinations reveal severe metabolic acidosis with increased anion gap and serum lactate elevation. Perturbations of hepatic and pancreatic enzyme values may exist. Echotomography and CT scan demonstrate fatty liver, confirmed by histological examination of the biopsy. Outcome in the intensive care unit is generally multiorgan failure and death. Symptomatic treatments, mechanical ventilation, bicarbonate infusion or hemodialysis appear to be ineffective in most severe cases. Pathophysiology: Antiretroviral nucleoside analogs are inhibitors of mitochondrial DNA polymerase gamma. This explains the dysfunction of the mitochondrial respiratory chain, leading to inhibition of lactate metabolism in the liver and enhancement of serum lactate and acetone body levels. Elevation of lactate/pyruvate and beta-hydroxybutyrate/acetoacetate ratios suggest mitochondrial dysfunction. Many other co-factors may be associated. Therapeutic approach: Several therapeutic strategies (thiamine, coenzyme<Aucun> Q, carnitine and riboflavin) have been tried. They rely on the pathophysiological hypothesis that sustained cellular dysfunctions cause this clinical syndrome.
引用
收藏
页码:2257 / 2264
页数:8
相关论文
共 50 条
  • [1] Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy
    Calza, L
    Manfredi, R
    Chiodo, F
    [J]. CLINICAL NUTRITION, 2005, 24 (01) : 5 - 15
  • [2] LACTIC-ACID ACIDOSIS IN HIV-INFECTED PATIENTS
    MASLO, C
    JACOMET, C
    JUPAS, JJ
    LEBRETTE, MG
    ROZENBAUM, W
    [J]. PRESSE MEDICALE, 1994, 23 (15): : 717 - 717
  • [3] Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy
    Vishal Patel
    S Susan Hedayati
    [J]. Nature Clinical Practice Nephrology, 2006, 2 : 109 - 114
  • [4] Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy
    Patel, V
    Hedayati, SS
    [J]. NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (02): : 109 - 114
  • [5] Lipodystrophic syndrome and antiretroviral treatments in HIV-infected patients
    Savès, M
    Merciè, P
    Chêne, G
    [J]. M S-MEDECINE SCIENCES, 2001, 17 (8-9): : 886 - 892
  • [6] Lactic acidosis related to nucleoside therapy in HIV-infected patients
    Falcó, V
    Crespo, M
    Ribera, E
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (08) : 1321 - 1329
  • [7] Adherence to antiretroviral treatments with a protease inhibitor in HIV-infected patients
    Salmon-Céron, D
    Deleuze, J
    Coste, J
    Guerin, C
    Ginsburg, C
    Blanche, P
    Finkielsztejn, L
    Pecqueux, L
    Chaput, S
    Gorin, I
    Sicard, D
    [J]. ANNALES DE MEDECINE INTERNE, 2000, 151 (04): : 297 - 302
  • [8] Lactic acidosis in HIV-infected patients: a systematic review of published cases
    Arenas-Pinto, A
    Grant, AD
    Edwards, S
    Weller, IVD
    [J]. ANTIVIRAL THERAPY, 2002, 7 (03) : L43 - L43
  • [9] Multiple mitochondrial DNA deletions and lactic acidosis in an HIV-infected patient under antiretroviral therapy
    Walker, UA
    Venhoff, N
    [J]. AIDS, 2001, 15 (11) : 1449 - 1450
  • [10] Lactic acidosis in HIV infected children due to antiretroviral therapy
    Shah, I
    [J]. INDIAN PEDIATRICS, 2005, 42 (10) : 1051 - 1052